APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lumpectomy

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

Selected research

Market Outlook & Growth Opportunities

Global Lumpectomy Market Outlook and Growth Opportunities 2026

1 January 2026194 pages

Choose your research edition.

Industry ResearchLumpectomy Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Lumpectomy Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Lumpectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lumpectomy Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Lumpectomy Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

The industry's leading producers are Hologic, BD and Danaher, which accounted for 40.13%, 11.79% and 11.27% of revenue in 2019, respectively.

Read the full market overview

This report provides an overview of the global Lumpectomy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lumpectomy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lumpectomy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lumpectomy market.

Lumpectomy Segment by Company

Hologic

BD

Danaher

Cook Medical

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Eckert & Ziegler

Theragenics

Sanarus

IsoAid

SOMATEX Medical

Ranfac

STERYLAB

Endomagnetics

Lumpectomy Segment by Type

Lumpectomy Systems

Lumpectomy Surgical Tools

Lumpectomy Segment by Application

Hospitals

Ambulatory Surgical Centers

Lumpectomy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lumpectomy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Lumpectomy key companies, revenue, market share, and recent developments.

3. To split the Lumpectomy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Lumpectomy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lumpectomy significant trends, drivers, influence factors in global and regions.

6. To analyze Lumpectomy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lumpectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lumpectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lumpectomy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lumpectomy industry.

Chapter 3: Detailed analysis of Lumpectomy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Lumpectomy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Lumpectomy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lumpectomy Industry Trends Table 2. Lumpectomy Industry Drivers Table 3. Lumpectomy Industry Opportunities and Challenges Table 4. Lumpectomy Industry Restraints Table 5. Global Lumpectomy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lumpectomy Revenue Share by Company (2021-2026) Table 7. Global Lumpectomy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Lumpectomy Key Company Manufacturing Base & Headquarters Table 9. Global Lumpectomy Company, Product Type & Application Table 10. Global Lumpectomy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Lumpectomy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Lumpectomy Systems Table 15. Significant Companies of Lumpectomy Surgical Tools Table 16. Global Lumpectomy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Lumpectomy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Lumpectomy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Lumpectomy Sales Value Share by Type (2021-2026) Table 20. Global Lumpectomy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Ambulatory Surgical Centers Table 23. Global Lumpectomy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Lumpectomy Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Lumpectomy Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Lumpectomy Sales Value Share by Application (2021-2026) Table 27. Global Lumpectomy Sales Value Share by Application (2027-2032) Table 28. Global Lumpectomy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Lumpectomy Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Lumpectomy Sales Value Share by Region (2021-2026) Table 31. Global Lumpectomy Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Lumpectomy Sales Value Share by Region (2027-2032) Table 33. Global Lumpectomy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lumpectomy Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Lumpectomy Sales Value Market Share by Country (2021-2026) Table 36. Global Lumpectomy Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Lumpectomy Sales Value Market Share by Country (2027-2032) Table 38. Hologic Company Information Table 39. Hologic Business Overview Table 40. Hologic Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Hologic Lumpectomy Product Portfolio Table 42. Hologic Recent Development Table 43. BD Company Information Table 44. BD Business Overview Table 45. BD Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. BD Lumpectomy Product Portfolio Table 47. BD Recent Development Table 48. Danaher Company Information Table 49. Danaher Business Overview Table 50. Danaher Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Danaher Lumpectomy Product Portfolio Table 52. Danaher Recent Development Table 53. Cook Medical Company Information Table 54. Cook Medical Business Overview Table 55. Cook Medical Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Cook Medical Lumpectomy Product Portfolio Table 57. Cook Medical Recent Development Table 58. Carl Zeiss Meditech Company Information Table 59. Carl Zeiss Meditech Business Overview Table 60. Carl Zeiss Meditech Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Carl Zeiss Meditech Lumpectomy Product Portfolio Table 62. Carl Zeiss Meditech Recent Development Table 63. Merit Medical Company Information Table 64. Merit Medical Business Overview Table 65. Merit Medical Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merit Medical Lumpectomy Product Portfolio Table 67. Merit Medical Recent Development Table 68. Argon Medical Devices Company Information Table 69. Argon Medical Devices Business Overview Table 70. Argon Medical Devices Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Argon Medical Devices Lumpectomy Product Portfolio Table 72. Argon Medical Devices Recent Development Table 73. Eckert & Ziegler Company Information Table 74. Eckert & Ziegler Business Overview Table 75. Eckert & Ziegler Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Eckert & Ziegler Lumpectomy Product Portfolio Table 77. Eckert & Ziegler Recent Development Table 78. Theragenics Company Information Table 79. Theragenics Business Overview Table 80. Theragenics Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Theragenics Lumpectomy Product Portfolio Table 82. Theragenics Recent Development Table 83. Sanarus Company Information Table 84. Sanarus Business Overview Table 85. Sanarus Lumpectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanarus Lumpectomy Product Portfolio Table 87. Sanarus Recent Development Table 88. IsoAid Company Information Table 89. IsoAid Business Overview Table 90. IsoAid Lumpectomy Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 91. IsoAid Lumpectomy Product Portfolio Table 92. IsoAid Recent Development Table 93. SOMATEX Medical Company Information Table 94. SOMATEX Medical Business Overview Table 95. SOMATEX Medical Lumpectomy Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 96. SOMATEX Medical Lumpectomy Product Portfolio Table 97. SOMATEX Medical Recent Development Table 98. Ranfac Company Information Table 99. Ranfac Business Overview Table 100. Ranfac Lumpectomy Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 101. Ranfac Lumpectomy Product Portfolio Table 102. Ranfac Recent Development Table 103. STERYLAB Company Information Table 104. STERYLAB Business Overview Table 105. STERYLAB Lumpectomy Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 106. STERYLAB Lumpectomy Product Portfolio Table 107. STERYLAB Recent Development Table 108. Endomagnetics Company Information Table 109. Endomagnetics Business Overview Table 110. Endomagnetics Lumpectomy Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 111. Endomagnetics Lumpectomy Product Portfolio Table 112. Endomagnetics Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Lumpectomy Product Image Figure 2. Global Lumpectomy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lumpectomy Market Size (2021-2032) & (US$ Million) Figure 4. Global Lumpectomy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Lumpectomy Systems Image Figure 8. Lumpectomy Surgical Tools Image Figure 9. Global Lumpectomy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Lumpectomy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Lumpectomy Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Ambulatory Surgical Centers Image Figure 14. Global Lumpectomy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lumpectomy Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lumpectomy Sales Value Share by Application (2021-2032) Figure 17. Global Lumpectomy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Lumpectomy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Lumpectomy Sales Value (2021-2032) & (US$ Million) Figure 20. North America Lumpectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Lumpectomy Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Lumpectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Lumpectomy Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Lumpectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Lumpectomy Sales Value (2021-2032) & (US$ Million) Figure 26. South America Lumpectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Lumpectomy Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Lumpectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Lumpectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Lumpectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Lumpectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Lumpectomy Systems
  • Lumpectomy Surgical Tools
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Hologic
  • BD
  • Danaher
  • Cook Medical
  • Carl Zeiss Meditech
  • Merit Medical
  • Argon Medical Devices
  • Eckert & Ziegler
  • Theragenics
  • Sanarus
  • IsoAid
  • SOMATEX Medical
  • Ranfac
  • STERYLAB
  • Endomagnetics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lumpectomy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lumpectomy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Lumpectomy Market Dynamics
  1. 2.1 Lumpectomy Industry Trends
  2. 2.2 Lumpectomy Industry Drivers
  3. 2.3 Lumpectomy Industry Opportunities and Challenges
  4. 2.4 Lumpectomy Industry Restraints
3 Lumpectomy Market by Company
  1. 3.1 Global Lumpectomy Company Revenue Ranking in 2025
  2. 3.2 Global Lumpectomy Revenue by Company (2021-2026)
  3. 3.3 Global Lumpectomy Company Ranking (2024-2026)
  4. 3.4 Global Lumpectomy Company Manufacturing Base and Headquarters
  5. 3.5 Global Lumpectomy Company Product Type and Application
  6. 3.6 Global Lumpectomy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Lumpectomy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Lumpectomy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Lumpectomy Market by Type
  1. 4.1 Lumpectomy Type Introduction
  2. 4.1.1 Lumpectomy Systems
  3. 4.1.2 Lumpectomy Surgical Tools
  4. 4.2 Global Lumpectomy Sales Value by Type
  5. 4.2.1 Global Lumpectomy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lumpectomy Sales Value by Type (2021-2032)
  7. 4.2.3 Global Lumpectomy Sales Value Share by Type (2021-2032)
5 Lumpectomy Market by Application
  1. 5.1 Lumpectomy Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Lumpectomy Sales Value by Application
  5. 5.2.1 Global Lumpectomy Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lumpectomy Sales Value by Application (2021-2032)
  7. 5.2.3 Global Lumpectomy Sales Value Share by Application (2021-2032)
6 Lumpectomy Regional Value Analysis
  1. 6.1 Global Lumpectomy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lumpectomy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Lumpectomy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Lumpectomy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lumpectomy Sales Value (2021-2032)
  7. 6.3.2 North America Lumpectomy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Lumpectomy Sales Value (2021-2032)
  10. 6.4.2 Europe Lumpectomy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Lumpectomy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Lumpectomy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Lumpectomy Sales Value (2021-2032)
  16. 6.6.2 South America Lumpectomy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Lumpectomy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Lumpectomy Sales Value Share by Country, 2025 VS 2032
7 Lumpectomy Country-level Value Analysis
  1. 7.1 Global Lumpectomy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lumpectomy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Lumpectomy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Lumpectomy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Lumpectomy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Lumpectomy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Lumpectomy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Lumpectomy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Lumpectomy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Lumpectomy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Lumpectomy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Lumpectomy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Lumpectomy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Lumpectomy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Lumpectomy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Lumpectomy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Lumpectomy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Lumpectomy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Lumpectomy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Lumpectomy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Lumpectomy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Lumpectomy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Lumpectomy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Lumpectomy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Lumpectomy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Lumpectomy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Lumpectomy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Lumpectomy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Lumpectomy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Lumpectomy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Lumpectomy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Lumpectomy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Lumpectomy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Lumpectomy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Lumpectomy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Lumpectomy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Lumpectomy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Lumpectomy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Lumpectomy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Lumpectomy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Lumpectomy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Lumpectomy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Lumpectomy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Lumpectomy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Lumpectomy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Lumpectomy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Lumpectomy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Lumpectomy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Lumpectomy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Lumpectomy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Lumpectomy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Lumpectomy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Lumpectomy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Lumpectomy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Lumpectomy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Lumpectomy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Lumpectomy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Lumpectomy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Lumpectomy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Lumpectomy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Lumpectomy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Lumpectomy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Lumpectomy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Lumpectomy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Lumpectomy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Lumpectomy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Lumpectomy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Lumpectomy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Lumpectomy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Lumpectomy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Lumpectomy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Lumpectomy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Lumpectomy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Lumpectomy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Lumpectomy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Lumpectomy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Lumpectomy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Lumpectomy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Lumpectomy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Lumpectomy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Lumpectomy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Lumpectomy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Lumpectomy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Lumpectomy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Lumpectomy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Lumpectomy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Lumpectomy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Lumpectomy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hologic
  2. 8.1.1 Hologic Company Information
  3. 8.1.2 Hologic Business Overview
  4. 8.1.3 Hologic Lumpectomy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hologic Lumpectomy Product Portfolio
  6. 8.1.5 Hologic Recent Developments
  7. 8.2 BD
  8. 8.2.1 BD Company Information
  9. 8.2.2 BD Business Overview
  10. 8.2.3 BD Lumpectomy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BD Lumpectomy Product Portfolio
  12. 8.2.5 BD Recent Developments
  13. 8.3 Danaher
  14. 8.3.1 Danaher Company Information
  15. 8.3.2 Danaher Business Overview
  16. 8.3.3 Danaher Lumpectomy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Danaher Lumpectomy Product Portfolio
  18. 8.3.5 Danaher Recent Developments
  19. 8.4 Cook Medical
  20. 8.4.1 Cook Medical Company Information
  21. 8.4.2 Cook Medical Business Overview
  22. 8.4.3 Cook Medical Lumpectomy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cook Medical Lumpectomy Product Portfolio
  24. 8.4.5 Cook Medical Recent Developments
  25. 8.5 Carl Zeiss Meditech
  26. 8.5.1 Carl Zeiss Meditech Company Information
  27. 8.5.2 Carl Zeiss Meditech Business Overview
  28. 8.5.3 Carl Zeiss Meditech Lumpectomy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Carl Zeiss Meditech Lumpectomy Product Portfolio
  30. 8.5.5 Carl Zeiss Meditech Recent Developments
  31. 8.6 Merit Medical
  32. 8.6.1 Merit Medical Company Information
  33. 8.6.2 Merit Medical Business Overview
  34. 8.6.3 Merit Medical Lumpectomy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merit Medical Lumpectomy Product Portfolio
  36. 8.6.5 Merit Medical Recent Developments
  37. 8.7 Argon Medical Devices
  38. 8.7.1 Argon Medical Devices Company Information
  39. 8.7.2 Argon Medical Devices Business Overview
  40. 8.7.3 Argon Medical Devices Lumpectomy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Argon Medical Devices Lumpectomy Product Portfolio
  42. 8.7.5 Argon Medical Devices Recent Developments
  43. 8.8 Eckert & Ziegler
  44. 8.8.1 Eckert & Ziegler Company Information
  45. 8.8.2 Eckert & Ziegler Business Overview
  46. 8.8.3 Eckert & Ziegler Lumpectomy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eckert & Ziegler Lumpectomy Product Portfolio
  48. 8.8.5 Eckert & Ziegler Recent Developments
  49. 8.9 Theragenics
  50. 8.9.1 Theragenics Company Information
  51. 8.9.2 Theragenics Business Overview
  52. 8.9.3 Theragenics Lumpectomy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Theragenics Lumpectomy Product Portfolio
  54. 8.9.5 Theragenics Recent Developments
  55. 8.10 Sanarus
  56. 8.10.1 Sanarus Company Information
  57. 8.10.2 Sanarus Business Overview
  58. 8.10.3 Sanarus Lumpectomy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanarus Lumpectomy Product Portfolio
  60. 8.10.5 Sanarus Recent Developments
  61. 8.11 IsoAid
  62. 8.11.1 IsoAid Company Information
  63. 8.11.2 IsoAid Business Overview
  64. 8.11.3 IsoAid Lumpectomy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 IsoAid Lumpectomy Product Portfolio
  66. 8.11.5 IsoAid Recent Developments
  67. 8.12 SOMATEX Medical
  68. 8.12.1 SOMATEX Medical Company Information
  69. 8.12.2 SOMATEX Medical Business Overview
  70. 8.12.3 SOMATEX Medical Lumpectomy Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SOMATEX Medical Lumpectomy Product Portfolio
  72. 8.12.5 SOMATEX Medical Recent Developments
  73. 8.13 Ranfac
  74. 8.13.1 Ranfac Company Information
  75. 8.13.2 Ranfac Business Overview
  76. 8.13.3 Ranfac Lumpectomy Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ranfac Lumpectomy Product Portfolio
  78. 8.13.5 Ranfac Recent Developments
  79. 8.14 STERYLAB
  80. 8.14.1 STERYLAB Company Information
  81. 8.14.2 STERYLAB Business Overview
  82. 8.14.3 STERYLAB Lumpectomy Revenue and Gross Margin (2021-2026)
  83. 8.14.4 STERYLAB Lumpectomy Product Portfolio
  84. 8.14.5 STERYLAB Recent Developments
  85. 8.15 Endomagnetics
  86. 8.15.1 Endomagnetics Company Information
  87. 8.15.2 Endomagnetics Business Overview
  88. 8.15.3 Endomagnetics Lumpectomy Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Endomagnetics Lumpectomy Product Portfolio
  90. 8.15.5 Endomagnetics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst